Reprint

Carbapenemase-Producing Enterobacterales

Edited by
April 2022
304 pages
  • ISBN978-3-0365-4030-6 (Hardback)
  • ISBN978-3-0365-4029-0 (PDF)

This is a Reprint of the Special Issue Carbapenemase-Producing Enterobacterales that was published in

Biology & Life Sciences
Medicine & Pharmacology
Summary

Carbapenem-resistant Enterobacterales (CRE) are a common cause of infections in both community and healthcare settings and have become an increasing threat to public health worldwide. The focus of this Special Issue includes aspects concerning plasmid-mediated antimicrobial resistance along with other carbapenem resistance mechanisms. Understanding the prevalence and routes of transmission of CRE is important in developing specific interventions for healthcare facilities, as well as the general impact of CRE circulation on the environment. Attention has also been focused on carbapenemase testing in order to provide advanced phenotypic and molecular assays for the identification of CRE, as a valid tool for active global surveillance, and from this perspective, the study of resistance mechanisms can provide significant support for the development of new and appropriate antimicrobial molecules. For all of these reasons, the phenomenon of carbapenem resistance deserves more attention, for the sake of public health.

Format
  • Hardback
License and Copyright
© 2022 by the authors; CC BY-NC-ND license
Keywords
carbapenem resistance; carbapenemase; whole genome sequencing; long reads, plasmid; Klebsiella pneumoniae; extensively drug-resistant; molecular typing; carbapenemases; Enterobacteriales; human; animal; food; environment; carbapenemase-producing Enterobacterales; KPC; carbapenem; multidrug resistance; nosocomial; Enterobacteriaceae; multidrug resistance; carbapenemase; ESBL; resistance genes; cattle; Klebsiella pneumoniae; carbapenemases; blaOXA-48; ERIC-PCR; plasmid profile analysis; biofilm formation; Enterobacteriaceae; PCR-based replicon typing; antibiotic-resistance; sequence types; multilocus sequence typing; plasmids; antimicrobial resistance; carbapenem inactivation method; carbapenem-resistant Enterobacterales; real-time multiplex PCR; whole-genome sequencing; carbapenem-resistance; Enterobacteriaceae; Qatar; CRE; OXA-48; carbapenems resistance; carbapenemases; Gram-negative bacteria; infection; colonization; COVID-19; K. pneumoniae; carbapenem resistance; OXA-48; porins; ceftazidime/avibactam; Klebsiella pneumoniae; ESKAPE; multidrug resistance; carbapenemases; healthcare-associated infections; antimicrobial peptides; Temporin L; Klebsiella michiganensis; Citrobacter farmeri; KPC-2; carbapenemase; plasmid; transposon; carbapenem-resistant Enterobacteriaceae (CRE); outbreak; infection control; pulsed-field gel electrophoresis (PFGE); multilocus sequence typing (MLST); carbapenemase; IMP-6; carbapenemase; porin; efflux pump; plasmid; nosocomial infections; carbapenemase-producing Enterobacterales; NDM-1; whole-genome sequencing; outbreak; Fourier transform infrared spectroscopy; infection control; carbapenemases; Eazyplex® SuperBug CRE assay; extended-spectrum beta-lactamases; gram-negative rods; LAMP method; Klebsiella pneumoniae; carbapenemases; NDM; KPC; VIM; OXA-48; molecular epidemiology; PFGE; Carbapenemase producing Enterobacterales; plasmid; IncX-3; NDM; carbapenem resistance; one health; water; environment; carbapenemase-producing Enterobacterales; colistin susceptibility testing; broth microdilution; colistin broth disc elution; Vitek 2 compact; rapid polymyxin NP test; Etest; ChromID colistin R agar; micronaut MIC-strip colistin; population analysis profiling; Enterobacterales; carbapenem resistance; neonates; plasmid-typing; sequence type; Klebsiella pneumoniae; wastewater; antimicrobial resistance; carbapenem resistance; virulence